Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Serina Therapeutics (SER) Return on Assets (2019 - 2025)

Serina Therapeutics (SER) has disclosed Return on Assets for 7 consecutive years, with 2.5% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 2.0% to 2.5% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2.5% through Dec 2025, down 2.0% year-over-year, with the annual reading at 2.81% for FY2025, 138.0% down from the prior year.
  • Return on Assets hit 2.5% in Q4 2025 for Serina Therapeutics, down from 2.19% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.04% in Q4 2021 to a low of 4.01% in Q4 2022.
  • Historically, Return on Assets has averaged 1.46% across 5 years, with a median of 1.02% in 2022.
  • Biggest five-year swings in Return on Assets: plummeted -397bps in 2022 and later skyrocketed 367bps in 2023.
  • Year by year, Return on Assets stood at 0.04% in 2021, then plummeted by -10761bps to 4.01% in 2022, then soared by 92bps to 0.34% in 2023, then tumbled by -630bps to 2.48% in 2024, then dropped by -1bps to 2.5% in 2025.
  • Business Quant data shows Return on Assets for SER at 2.5% in Q4 2025, 2.19% in Q3 2025, and 2.85% in Q2 2025.